IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lion Point Capital, LP

Q4 2023 Holdings

Filed 2024-02-14 | 30 holdings | $199.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Semtech Corp(SMTC)COM816850101$56.5M2,577,85528.3%
Semtech Corp(SMTC)CallCOM816850101$54.8M2,500,00027.4%
Ishares TR(IWM)PutRUSSELL 2000 ETF464287655$33.1M165,00016.6%
Marinus Pharmaceuticals Inc(MRNS*)COM NEW56854Q200$23.2M2,134,33711.6%
Ardelyx Inc(ARDX)COM039697107$7.1M1,151,6673.6%
Milestone Pharmaceuticals in(MIST)COM59935V107$2.8M1,650,2071.4%
Harpoon Therapeutics IncCOM NEW41358P205$2.6M228,9001.3%
Burgerfi International Inc(0LS)COM12122L101$2.4M2,745,9381.2%
Kiniksa Pharmaceuticals LTDCOM CL AG5269C101$2.3M130,6911.1%
Insmed Inc(INSM)COM PAR $.01457669307$2.2M70,3351.1%
Battalion Oil Corporation(BATL)COM07134L107$2.1M222,1821.1%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$1.9M82,4251.0%
Fennec Pharmaceuticals Inc(FENC)COM31447P100$1.2M110,0000.6%
Avadel Pharmaceuticals PLCSPONSORED ADR05337M104$1.1M80,0000.6%
Enphys Acquisition CorpCL A ORD SHSG3167L109$833.6K78,1250.4%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$745.5K34,5000.4%
Bluebird BIO IncCOM09609G100$733.1K531,2560.4%
Travere Therapeutics Inc(TVTX)COM89422G107$701.2K78,0000.4%
Travere Therapeutics IncNOTE 2.250% 3/089422GAA5$670.7K$1,000,0000.3%
Humacyte Inc(HUMA)COM44486Q103$667.4K235,0000.3%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$477.1K340,7610.2%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$398.5K13,5000.2%
Replimune Group Inc(REPL)COM76029N106$358.3K42,5000.2%
Lumos Pharma IncCOM55028X109$288.7K90,7940.1%
Amylyx Pharmaceuticals Inc(AMLX)COM03237H101$206.1K14,0000.1%
Aadi Bioscience Inc(WHWK)COM00032Q104$166.5K82,4230.1%
Aclaris Therapeutics Inc(ACRS)COM00461U105$121.7K115,8980.1%
Burgerfi International Inc*W EXP 12/16/20212122L119$93.8K2,083,4380.0%
Microsoft Corp(MSFT)COM594918104$37.6K1000.0%
Alphabet Inc(GOOG)CAP STK CL C02079K107$14.1K1000.0%